J. Fuente

发表

Consensus on the use of Rituximab in Rheumatoid Arthritis. A document with evidence based recommendations

J. Gómez-Reino, R. Sanmartí, A. Balsa, 2011 .

Fever and exanthema in a young patient: drug reaction with eosinophilia and systemic symptoms due to allopurinol.

S. R. Rodríguez Montero, M. L. Velloso Feijoó, J. Fuente, 2013 .

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

U. Wagner, A. Gottlieb, A. Orbai, 2017, The Lancet.

Langerhans cell histiocytosis of the vulva

C. Ferrándiz, M. Ribera, I. Bielsa, 1996 .

Anti‐U and haemolytic disease of the fetus and newborn

N. Win, J. Fuente, P. Knott, 1998, British journal of obstetrics and gynaecology.

Plasma cell myeloma presented as myelomatous meningitis

I. Prieto, N. Somolinos, B. Sopeña, 1994, European journal of haematology.

Resistant orbital pseudotumor treated with rituximab in a patient with systemic lupus erythematosus. A case presentation

J. Fuente, Carmen González, M. Feijóo, 2010 .

Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis

J. Andreu, E. Mola, J. Álvaro-Gracia, 2010 .

Steroids treatment of granulomatous hepatitis complicatingCoxiella burnetii acute infection

M. Rubianes, J. Bordón, B. Sopeña, 1999, Infection.

Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis

J. Andreu, E. Mola, J. Álvaro-Gracia, 2010 .